• Vol. 51 No. 10, 629–636
  • 26 October 2022

Nutrition therapy in the older critically ill patients: A scoping review

473



0 Citing Article
473 Views
199 Downloads

Download PDF

ABSTRACT

Introduction: There is a lack of guidelines or formal systematic synthesis of evidence for nutrition therapy in older critically ill patients. This study is a scoping review to explore the state of evidence in this population.

Method: MEDLINE and Embase were searched from inception until 9 February 2022 for studies that enrolled critically ill patients aged ≥60 years and investigated any area of nutrition therapy. No language or study design restrictions were applied.

Results: Thirty-two studies (5 randomised controlled trials) with 6 topics were identified: (1) nutrition screening and assessments, (2) muscle mass assessment, (3) route or timing of nutrition therapy, (4) determination of energy and protein requirements, (5) energy and protein intake, and (6) pharmaconutrition. Topics (1), (3) and (6) had similar findings among general adult intensive care unit (ICU) patients. Skeletal muscle mass at ICU admission was significantly lower in older versus young patients. Among older ICU patients, low muscularity at ICU admission increased the risk of adverse outcomes. Predicted energy requirements using weight-based equations significantly deviated from indirect calorimetry measurements in older vs younger patients. Older ICU patients required higher protein intake (>1.5g/kg/day) than younger patients to achieve nitrogen balance. However, at similar protein intake, older patients had a higher risk of azotaemia.

Conclusion: Based on limited evidence, assessment of muscle mass, indirect calorimetry and careful monitoring of urea level may be important to guide nutrition therapy in older ICU patients. Other nutrition recommendations for general ICU patients may be used for older patients with sound clinical discretion.


The increasing levels of life expectancy and decreasing fertility are shifting the age structure of the world population towards older ages.1 From year 2020 to 2050, population aged ≥65 years is expected to rise from 9.3% to 16%.1 The number of older intensive care unit (ICU) patients are expected to rise correspondingly.

The growing number of older patients may warrant more specific nutrition recommendation. Ageing is associated with increased fat mass and decreased muscle mass.2 These changes in body composition may have important implications to nutritional requirements and metabolism. However, to date, no guidelines for nutrition therapy specifically for older ICU patients exist. This might be due to the lack of systematic summary of critical care nutrition studies on older patients. Nevertheless, several narrative reviews are available to provide recommendations based on expert opinion.3,4 Therefore, we aimed to systematically search the literature and explore the state of evidence of critical care nutrition in older ICU patients through a scoping review.

METHOD

This scoping review is conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) extension for scoping reviews checklist (online Supplementary Materials, Supplementary Appendix S1).5

We included original studies that enrolled critically ill patients aged ≥60 years, and investigated any area related to critical care nutrition. Conference abstracts and studies that did not enrol critically ill patients or investigate any nutrition-related topics were excluded. We searched MEDLINE and Embase from inception until 9 February 2022. The detailed search strategy is available in the online Supplementary Appendix S2. No language or study design restrictions were applied. The search was supplemented by screening the reference lists of published reviews.

We imported all references into Covidence (Veritas Health Innovation, Melbourne, Australia) to screen them and remove duplication. Two authors screened the titles and abstracts, and reviewed the full-text article of the potential studies to confirm their eligibility. Disagreements were resolved by consulting a third senior author.

Based on the authors’ judgement, the included studies were grouped based on the topic investigated. The characteristics (e.g. first author name, year of publication, study design, sample size, mean/median age of patients) and main findings of the studies were summarised in separate tables for each topic identified in the included studies. Each co-author was assigned a topic to summarise, and accuracy of this was checked by the first author A generic table was provided to each co-author, which can be adapted to suit the summary work of each assigned topic. Critical appraisal of the included studies was not performed.

Post hoc, since there were limited ICU studies that specifically recruited older adults, we decided to include studies that enrolled adult patients but had subgroup analyses of older versus younger patients. However, such analyses were not apparent in the title or abstract, which reduced identifiability Hence, we only reported findings in the eligible studies and those that were known to the authors.

RESULTS

The databases identified 4,689 references, and 81 full-text articles were retrieved. About 1,148 citations were screened from previous review articles. Online Supplementary Appendix S3 shows the PRISMA flowchart and Appendix S4 lists the reason of exclusion of all retrieved studies that were excluded. We included 32 original studies, of which 5 were randomised controlled trials (RCTs). These studies were published from 1997 to 2021, with sample sizes ranging from 25–1,279. They were divided into 6 topics: nutrition screening and assessments (n=10), muscle mass assessment (n=5), route or timing of nutrition therapy (n=3, including 2 RCTs), determination of energy and protein requirements (n=6), energy and protein intake (n=4), and pharmaconutrition (n=4, including 3 RCTs).

Nutrition screening and assessments

Ten observational studies (5 prospective and 5 retrospective) were included, with sample sizes ranging from 87–1,250 (online Supplementary Materials, Supplementary Table S1).

Prevalence data

Studies that used validated nutrition assessment tools in critically ill patients6 (i.e. Subjective Global Assessment [SGA]7,8 and Mini Nutrition Assessment [MNA])8 showed that malnutrition prevalence in older patients ranged from 23.2–34.4%. Studies that used validated nutrition screening tools (i.e. MNA-short form [MNA-SF],8 Nutrition Risk Screening 2002 [NRS-2002],8-10 and Malnutrition Universal Screening Tool [MUST])11 found that malnutrition-risk prevalence ranged from 25.8–71.2%. Other studies used nutrition screening tools that mainly relied on biochemical indices such as serum albumin (i.e. controlling nutritional status index [CONUT],12 prognostic nutritional index [PNI],12 geriatric nutritional risk index [GNRI],10,11,14 and Onodera’s prognostic nutritional index [OPNI]).10 They reported 43.9–76.3% of older ICU patients had biochemical derangements. A study that used mid-arm circumference reported that 23.3% of older ICU patients had measurements below the 10th percentile of a population-specific database.15 One study that used an ICU-specific nutrition score (modified nutrition risk in critically ill [mNUTRIC])11 reported nutrition risk in 91.1% of the older ICU patients.

Prognostic data

Malnutrition assessed by the SGA, but not MNA, was associated with hospital mortality/needing hospice care and lower risk of being discharged home.8 However, it was not associated with ICU and hospital length of stay (LOS).8

Malnutrition risk identified by NRS-2002 and MNA-SF was associated with a higher risk of hospital mortality/needing hospice care, but only NRS-2002 could prognose the risk of being discharged home.8 Malnutrition risk identified by NRS-2002 was also associated with an increased risk of infection, complications, ICU mortality and longer ICU LOS.9 Malnutrition risk defined by MUST was associated with higher mortality at 1-year post-discharge.11

Biochemical derangement measured by GNRI was associated with mortality (hospital or 30-day) and hospital LOS,10,13,14 but not associated with ICU mortality and ICU LOS.15 Similarly, biochemical derangements measured by CONUT and PNI were not associated with ICU mortality.12

Low mid-arm circumference was associated with a higher risk of 6-month mortality.15 Older ICU patients with high mNUTRIC score had increased ICU, hospital or 30-day mortality, and ICU/ hospital length of stay.10,16 However, patients with high mNUTRIC and achieved ≥80% prescribed calories and protein had lower ICU and/or hospital mortality.16

Muscle mass assessment

Five observational studies were included (2 prospective, 2 retrospective and 1 case-control study) with sample sizes ranging from 50–150 patients. All studies used imaging methods to assess muscle mass (online Supplementary Table S2).

Three studies assessed muscle mass using computed tomography (CT) scan and enrolled ICU patients aged ≥6017,18 or ≥65.19 Two studies measured skeletal muscle index19 or skeletal muscle area (SMA)17 at the third lumbar vertebral level (L3), and 1 study measured the dorsal muscle group area at the twelfth thoracic vertebral level.18 The definitions for low muscularity (LM) used were from cancer patients,20 ICU patients,21 or derived internally.18 The prevalence of LM was 71% in 1 study.19 All studies found that muscularity status was associated with hospital mortality.17-19 Furthermore, LM was associated with lower ventilation-free days and ICU-free days.19

Two studies enrolled adult ICU patients and demonstrated that older patients had significantly lower SMA at L322,23 and a higher prevalence of low muscularity,22 compared to younger patients. Using ultrasound, 1 study found that mid-upper arm, forearm, abdomen and thighs muscularity was significantly lower in older than younger patients.23 However, another study could not demonstrate a significant difference in quadriceps muscle layer thickness between older or younger ICU patients (1.2±0.5cm vs 1.4±0.7cm, respectively; P=0.57).22

Route or timing of nutrition therapy

Two RCTs and 1 retrospective observational study were included, with sample sizes ranging from 141–325 patients (online Supplementary Table S3). The first RCT investigated the effect of enteral nutrition (EN), parenteral nutrition (PN), and combined EN with supplemental PN.24 Patients on PN had a higher rate of infectious and non-infectious complications than the other 2 groups. In contrast, mechanical ventilation (MV) duration, ICU and hospital LOS, and 20-day mortality were all significantly lower in the combined EN and supplemental PN groups compared to EN or PN group. The energy and protein received by each group was not reported.24 The second RCT assigned patients to postpyloric vs gastric EN, and found that the incidences of ventilator-associated pneumonia, vomiting and abdominal distension were significantly lower in the postpyloric group. However, this was not translated into lower use of renal replacement therapy, shorter MV duration, ICU and hospital LOS, or a lower rate of ICU and hospital mortality.25 Lastly, an observational study among older ICU patients with thermal injuries reported that early (<24h), compared with late (>24h) EN initiation was associated with a shorter ICU and hospital LOS, and a lower risk of sepsis, superficial skin infection, pneumonia and mortality.26

Determination of energy and protein requirements

Three prospective and 2 retrospective observational studies were included (online Supplementary Table S4), with sample sizes ranging from 25–103 patients. All studies included MV patients and found that predictive equations were not ideal in predicting resting energy expenditure (REE) measured by indirect calorimetry (IC) in older patients.27-31

Among 8 unique predictive equations with their variants, 1 study found that the Penn State (PSU) equation that included the Mifflin-St Jeor equation was the best equation for non-obese older (≥60 years) ICU patients.28 Among obese older ICU patients, the PSU (modified) equation may be the best choice.29 In another study comparing 6 predictive equations (without the PSU equation), the Harris-Benedict equation with a correction factor of 1.2 agreed most closely with IC measurements.30

In studies comparing older vs younger patients, measured resting metabolic rate (after controlling for basal metabolic rate)32 or REE31 was not different between groups. However, the absolute deviation (either over- or underestimation) of predicted (25 kcal*ideal body weight in kg) from measured REE was significantly higher in older vs younger patients (9.3±6.9 vs 6.3±6.6kcal/kg, respectively; P<0.01).31 In critically ill trauma patients, the incidence of azotaemia (blood urea nitrogen >25mg/dL) was higher among older than younger patients with similar protein intake.32

Energy and protein intake

Four retrospective observational studies were included, with sample sizes of 55–1,279 (online Supplementary Table S5).

Three retrospective studies were conducted on critically ill trauma patients. The first study investigated a hypocaloric (21–25kcal/kg/day), high protein (≥2g/kg/day) regime for >10 days. No differences in nitrogen balance or clinical outcomes were found between older vs younger group.33 Another study found that nitrogen balance can only be improved with a protein intake of >1.5g/kg/day in older patients, compared with >0.99g/kg/day in younger patients.34 The third study showed that the calories received did not predict the time-to-discharge alive from the hospital for both older and younger groups.35 Among MV COVID-19 patients, a retrospective analysis found no correlation between calories and protein intake with ICU LOS, hospital LOS, length of vasopressor use, and duration of MV in the older or the younger group.36

Pharmaconutrition

Four studies (3 RCTs and 1 non-randomised interventional trial) investigated the effect of pharmaconutrition (intravenous [IV] glutamine, EN glutamine or IV fish oils) in older ICU patients (online Supplementary Table S6).

Two RCTs from the same group of authors randomised patients into 3 groups (control vs IV glutamine vs IV glutamine + intramuscular recombinant human growth hormone)37 and 2 groups (control vs IV glutamine).38 IV glutamine was administered at 100mL/day for 2 weeks. Both studies found that IV glutamine reduced Acute Physiology and Chronic Health Evaluation II (APACHE II) and multiple organ dysfunction syndrome (MODS) scores at day 14, but this was not translated into improvements in MV duration, ICU LOS, or 28-day survival rate.37,39

One non-randomised trial compared standard EN vs IV fish oils at a dose of 0.2g lipid/kg body weight over 6 hours for 3 consecutive days. No differences were found between groups for ICU LOS, duration of MV and ICU mortality.38

The last study randomised patients into total parenteral nutrition (TPN) with gradual transition to full EN; EN + lower glutamine dose (0.3g/kg/day); and EN + higher glutamine dose (0.6g/kg/day). Compared to the TPN group, both glutamine groups had higher transferrin and prealbumin levels at day 7, and higher haemoglobin level at day 14. There was no difference in the incidence of diarrhoea and bloating between the groups at day 7 and 14. No clinical outcomes were reported.40

DISCUSSION

This scoping review found limited evidence for nutrition therapy in older critically ill patients. There were only 5 RCTs (sample size range: 90–147 patients) for 2 topics: route or timing of nutrition therapy and pharmaconutrition. In contrast, among general critically ill patients, up to December 2008, there were already 207 RCTs with 23,091 patients across 34 topics.41 The results of each topic are discussed in the following sections.

Nutrition screening and assessments

Determination of malnutrition and its risk among ICU patients is important for prognostication and may be used to guide nutrition intervention. This is especially relevant for older patients as they may be at higher risk of malnutrition or already malnourished before ICU admission due to various physical or social factors.42 Of the 2 nutrition assessment tools (SGA and MNA), only SGA could prognose poorer clinical outcomes, and it is the most validated nutrition assessment tool in the general critically ill patients.6 Of note, mid-arm circumference, a unidimensional assessment, may be inadequate to assess for malnutrition.

The American Society for Parenteral and Enteral Nutrition 2016 guidelines recommended using NRS-2002 and NUTRIC/mNUTRIC score to guide nutrition intervention.43 Notably, only the NUTRIC/mNUTRIC was developed and validated among critically ill patients.44,45 Hsu et al. reported that most older ICU patients had high mNUTRIC score (91.1%), and achieving ≥80% of prescribed calories and protein was associated with lower mortality.16 However, the result of this observational study needs to be confirmed by high-quality RCTs.

Tools such as CONUT, GNRI, PNI and OPNI use biochemical markers like serum albumin and total lymphocytes to establish malnutrition risk. However, serum albumin and lymphocytes in an acute clinical setting reflect inflammatory status and disease severity rather than nutritional status.46 These markers may have some prognostic value but using such tools may misguide treatment as they do not respond to nutritional interventions in an acute setting.46

Similar to general adult critically ill patients, current evidence suggests that mNUTRIC and SGA may be the best available tools to aid prognostication of clinical outcomes in older critically ill patients. High-quality RCTs are needed to determine whether these tools can identify patients who may benefit from higher nutrition delivery.

Muscle mass assessment      

Skeletal muscle is the most abundant tissue and the main reservoir of amino acids for vital organs during the stressed state.47,48 The direct measurements of muscle mass using imaging procedures such as CT and ultrasound at ICU admission may more precisely reflect patients’ nutritional status.49 Indeed, 3 studies consistently demonstrated higher hospital mortality in older critically ill patients with low muscularity at ICU admission.17-19 Compared to younger patients, older patients tended to have lower skeletal muscle mass and higher prevalence of low muscularity at ICU admission.22,23 For this reason, older ICU patients may experience greater nutrition-related complications than younger patients. Therefore, it may be crucial for older critically ill patients to receive early nutrition assessment and intervention. Further investigation is needed to determine whether a nutrition intervention that is tailored to age and/or muscularity status will result in improved clinical and functional outcomes.

Route or timing of nutrition therapy

First, it is well established that in haemodynamically stable patients with functional gastrointestinal tract, early rather than delayed EN is associated with significant clinical benefit.50 Second, postpyloric EN is also known to reduce the risk of pneumonia and gastrointestinal complications without reducing the risk of mortality.52 Regarding EN vs PN, infectious complications were found to be greater in the PN group if the calories received are higher than in the EN group.52 However, the actual energy and protein received between groups were not reported.24 The included study found significant clinical benefits of combining EN and PN;24 however, this is not supported by a meta-analysis of RCTs in general ICU patients.53 Overall, the evidence regarding the route and timing of nutrition therapy is limited but unlikely to be different from the findings of general critically ill patients.

Determination of energy and protein requirements

In general, REE should be measured using IC when available and feasible. In situations when IC measurements are not possible, PSU (Mifflin) or PSU (modified) may be used for non-obese and obese older critically ill patients, respectively. However, the PSU equations were developed >10 years ago and based on a Caucasian population.28,29 It may be more appropriate to use a population-specific equation that is developed among critically ill patients, if available.54,55 On the other hand, the benefits of using IC in older ICU patients remain unclear since none of the included studies investigated clinical outcomes. Recently, a systematic review and meta-analysis of RCTs demonstrated that IC-targeted energy delivery significantly reduced short-term mortality.56

Weight-based predictive equations were less accurate in older vs younger patients,31 and older patients were also at higher risk of azotaemia than younger patients at similar protein intake.32 Based on these limited evidence, the use of IC (if feasible) or age- and population-specific predictive equations, and careful monitoring of urea levels may be used to guide energy and protein prescription, respectively, in older ICU patients. Other protein monitoring strategies such as nitrogen balance, urea/creatinine ratio and monitoring of muscle mass trajectory may also be useful, though current evidence is lacking in this population.

Energy and protein intake

Older, compared to younger patients, required higher protein to achieve nitrogen balance (1.5 vs 0.99g/kg/day);34 however, calories and protein intake were not associated with any clinical outcomes.35,36 This is similar to 2 meta-analyses of RCTs in general ICU patients showing that higher calories and/or protein intake were not associated with any improvement in clinical outcomes.57,58 Overall, the optimal energy and protein dose for older critically ill patients are yet to be determined. Physiologic data suggest that older patients require higher protein intake than younger patients;34 however, caution needs to be exercised with higher protein as older patients are at a higher risk of azotaemia than younger patients at similar protein intake.31

Pharmaconutrition

The use of IV or EN glutamine and IV fish oils were not associated with clinical outcomes,37-39 despite 2 studies showing improvement of APACHE II and MODS scores in the IV glutamine group.37,39 Generally, the routine use of glutamine is not recommended except in burns and trauma ICU patients.43,59 A recent meta-analysis of RCTs demonstrated that fish oils as part of PN formula or administered as a standalone medication was associated with improved clinical outcomes.60 Further studies are needed to elucidate whether the treatment effect of pharmaconutrition is different in older vs younger patients.

Limitations

The low number and poor quality of evidence of the included studies for each topic preclude any reliable conclusion or clinical recommendations. These findings will hopefully encourage more high-quality original nutrition studies in this increasing population. The selection of studies with subgroup analysis of older vs younger patients that are known to the authors may have contributed to bias in the findings. However, we disclosed this in the methodology, and the similarity of our findings with published recommendations for general critically ill patients attest to a low risk of bias.61 Future research may continue to build on our work by adding more studies that might have been missed by us into our tables.

This review did not identify studies on other aspects of critical care nutrition such as the use of micronutrients, monitoring of feeding tolerance, refeeding syndrome and glycaemic control; or the use of supplementation such as hydroxymethylbutyrate and leucine in older patients with sarcopenia; or the effect of nutrition on functional outcomes. More studies are needed in these aspects.


SUPPLEMENTARY MATERIALS


REFERENCES

    1. United Nations Department of Economic and Social Affairs, Population Division. World Population Ageing 2020 Highlights: Living Arrangements of Older Persons, 2020.
    2. St-Onge MP, Gallagher D. Body composition changes with aging: The cause or the result of alterations in metabolic rate and macronutrient oxidation? Nutrition 2010;26:152-5.
    3. Singh P, Gupta M, Lehl SS. Nutrition therapy in critically ill elderly patients. Int J Adv Med 2014;1:3-8.
    4. Tatucu-Babet OA, Lambell K, Ridley EJ. Nutritional management of the critically ill older adult. ICU Manag Pract 2020;20:185-90.
    5. Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med 2018;169:467-73.
    6. Lew CCH, Yandell R, Fraser RJL, et al. Association between malnutrition and clinical outcomes in the intensive care unit: a systematic review. JPEN J Parenter Enteral Nutr 2017;41:744-58.
    7. Atalay BG, Yagmur C, Nursal TZ, et al. Use of subjective global assessment and clinical outcomes in critically ill geriatric patients receiving nutrition support. JPEN J Parenter Enter Nutr 2008;32:454-9.
    8. Sheean PM, Peterson SJ, Chen Y, et al. Utilizing multiple methods to classify malnutrition among elderly patients admitted to the medical and surgical intensive care units (ICU). Clin Nutr 2013;32:752-7.
    9. Shpata V, Ohri I, Nurka T, et al. The prevalence and consequences of malnutrition risk in elderly Albanian intensive care unit patients. Clin Interv Aging 2015;10:481-6.
    10. Yenibertiz D, Cirik MO. The comparison of GNRI and other nutritional indexes on short-term survival in geriatric patients treated for respiratory failure. Aging Clin Exp Res 2021;33:611-7.
    11. Tripathy S, Mishra JC, Dash SC. Critically ill elderly patients in a developing world—mortality and functional outcome at 1 year: A prospective single-center study. J Crit Care 2014;29:474.e7-13.
    12. Kos M, Titiz H, Onec B, et al. Association of “Controlling Nutritional Status Index” and “Prognostic Nutritional Index” with intensive care unit survival in elderly patients. Eur Geriatr Med 2016;7:13-7.
    13. Liu H, Wu SC, Tsai CH, et al. Association between geriatric nutritional risk index and mortality in older trauma patients in the intensive care unit. Nutrients 2020;12:3861.
    14. Shi X, Shen Y, Yang J, et al. The relationship of the geriatric nutritional risk index to mortality and length of stay in elderly patients with acute respiratory failure: A retrospective cohort study. Heart Lung 2021;50:898-905.
    15. Dardaine V, Dequin PF, Ripault H, et al. Outcome of older patients requiring ventilatory support in intensive care: Impact of nutritional status. J Am Geriatr Soc 2001;49:564-70.
    16. Hsu PH, Lee CH, Kuo LK, et al. Higher energy and protein intake from enteral nutrition may reduce hospital mortality in mechanically ventilated critically ill elderly patients. Int J Gerontol 2018;12:285-9.
    17. Shibahashi K, Sugiyama K, Kashiura M, et al. Decreasing skeletal muscle as a risk factor for mortality in elderly patients with sepsis: a retrospective cohort study. J Intensive Care. 2017;5:8.
    18. Zhi J, Shan Q, Liang L, et al. Low skeletal muscle area as a prognostic marker for chronic obstructive pulmonary disease in elderly patients admitted to ICU. Sci Re. 2019;9:19117.
    19. Moisey LL, Mourtzakis M, Cotton BA, et al. Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients. Crit Care 2013;17:R206.
    20. Mourtzakis M, Prado CMM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008;33:997-1006.
    21. Weijs PJM, Looijaard WGPM, Dekker IM, et al. Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients. Crit Care 2014;18:R12.
    22. Paris MT, Mourtzakis M, Day A, et al. Validation of bedside ultrasound of muscle layer thickness of the quadriceps in the critically ill patient (VALIDUM Study). JPEN J Parenter Enteral Nutr 2017;41:171-80.
    23. Lambell KJ, Tierney AC, Wang JC, et al. Comparison of ultrasound-derived muscle thickness with computed tomography muscle cross-sectional area on admission to the intensive care unit: A pilot cross-sectional study. JPEN J Parenter Enteral Nutr 2021;45:136-45.
    24. Chen F, Wang J, Jiang Y. Influence of different routes of nutrition on the respiratory muscle strength and outcome of elderly patients in respiratory intensive care unit. Chinese J Clin Nutr 2011;19:7-11.
    25. Zhu Y, Yin H, Zhang R, et al. Gastric versus postpyloric enteral nutrition in elderly patients (age ≥ 75 years) on mechanical ventilation: A single-center randomized trial. Crit Care 2018;22:170.
    26. Castanon L, Asmar S, Bible L, et al. Early enteral nutrition in geriatric burn patients: Is there a benefit? J Burn Care Res 2020;41:986-991.
    27. Sheridan R, Prelack K, Yin L, et al. Energy needs are poorly predicted in critically ill elderly. J Intensive Care Med 1997;12:45-9.
    28. Frankenfield DC, Coleman A, Alam S, et al. Analysis of estimation methods for resting metabolic rate in critically ill adults. JPEN J Parenter Enteral Nutr 2009;33:27-36.
    29. Frankenfield D. Validation of an equation for resting metabolic rate in older obese, critically ill patients. JPEN J Parenter Enteral Nutr 2011;35:264-9.
    30. Segadilha NLAL, Rocha EEM, Tanaka LMS, et al. Energy expenditure in critically ill elderly patients: indirect calorimetry vs predictive equations. JPEN J Parenter Enteral Nutr 2017;41:776-84.
    31. Ebihara T, Shimizu K, Ojima M, et al. Energy expenditure and oxygen uptake kinetics in critically ill elderly patients. JPEN J Parenter Enteral Nutr 2022;46:75-82.
    32. Frankenfield D, Cooney RN, Smith JS, et al. Age-related differences in the metabolic response to injury. J Trauma 2000;48:49-56; discussion 56-7.
    33. Dickerson RN, Medling TL, Smith AC, et al. Hypocaloric, high-protein nutrition therapy in older vs younger critically ill patients with obesity. JPEN J Parenter Enteral Nutr 2013;37:342-51.
    34. Dickerson RN, Maish GO III, Croce MA, et al. Influence of aging on nitrogen accretion during critical illness. JPEN J Parenter Enteral Nutr 2015;39:282-90.
    35. Wade CE, Kozar RA, Dyer CB, et al Evaluation of nutrition deficits in adult and elderly trauma patients. JPEN J Parenter Enteral Nutr 2015;39:449-55.
    36. Tañada MRPK, Tanchee-Ngo MJ. Association of protein-calorie intake and clinical outcomes among critically-ill covid-19 patients: A retrospective study. Philipp J Intern Med 2021;59:246-54.
    37. Cai G, Yan J, Zhang Z, Yu Y. Immunomodulatory effects of glutamine-enriched nutritional support in elderly patients with severe sepsis: A prospective, randomized, controlled study. J Organ Dysfunct 2008;4:31-7.
    38. Barros KV, Cassulino AP, Schalch L, et al. Supplemental intravenous n-3 fatty acids and n-3 fatty acid status and outcome incritically ill elderly patients in the ICU receiving enteral nutrition. Clin Nutr 2013;32:599-605.
    39. Cai GL, Yan J, Yu YH, et al. [Influence of glutamine and growth hormone intensified nutrition support on immunomodulation in critically ill elderly patients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006;18:595-8.
    40. Han W, Sun J, Han R, et al. Application of enteral nutrition support with different doses of glutamine in elderly critically ill patients. Chinese J Clin Nutr 2014;22:149-53.
    41. Heyland DK, Heyland J, Dhaliwal R, et al. Randomized trials in critical care nutrition: Look how far we’ve come! (And Where Do We Go from Here?). JPEN J Parenter Enteral Nutr 2010;34:697-706.
    42. Norman K, Haß U, Pirlich M. Malnutrition in older adults—recent advances and remaining challenges. Nutrients 2021;13:2764.
    43. McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2016;40:159-211.
    44. Heyland DK, Dhaliwal R, Jiang X, et al. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Crit care 2011;15:R268.
    45. Rahman A, Hasan RM, Agarwala R, et al. Identifying critically-ill patients who will benefit most from nutritional therapy: Further validation of the “modified NUTRIC” nutritional risk assessment tool. Clin Nutr 2016;35:158-62.
    46. Evans DC, Corkins MR, Malone A, et al. The use of visceral proteins as nutrition markers: an ASPEN position paper. Nutr Clin Pract 2021;36:22-8.
    47. Wang ZM, Pierson RN Jr, Heymsfield SB. The five-level model: A new approach to organizing body-composition research. Am J Clin Nutr 1992;56:19-28.
    48. Frontera WR, Ochala J. Skeletal muscle: a brief review of structure and function. Calcif Tissue Int 2015;96:183-95.
    49. Barazzoni R, Jensen GL, Correia MITD, et al. Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition (GLIM) diagnosis of malnutrition. Clin Nutr 2022;41:1425-33.
    50. Reintam Blaser A, Starkopf J, Alhazzani W, et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med 2017;43:380-98.
    51. Heyland DK, Lee Z-Y, Lew CCH, et al. 6.2 Strategies to Optimize Delivery and Minimize Risks of EN: Small Bowel Feeding vs. Gastric. Critical Care Nutrition Systematic Reviews, May 2021. https://criticalcarenutrition.com/docs/6.2%20EN-Small%20Bowel%20vs%20Gastric%20Feeding_May2021.pdf. Accessed 27 April 2022.
    52. Heyland DK, Lee Z-Y, Lew CCH, et al. 2.0 The use of Enteral Nutrition vs Parenteral Nutrition. Critical Care Nutrition: Systematic Reviews, February 2021. https://criticalcarenutrition.com/docs/2.0%20EN%20vs%20PN_Feb2021.pdf. Accessed 27 April 2022.
    53. Heyland DK, Lee Z-Y, Lew CCH, et al. 7.1 Combination Parenteral Nutrition and Enteral Nutrition. Critical Care Nutrition: Systematic Reviews, May 2021. https://criticalcarenutrition.com/docs/7.1%20EN+PN_May2021.pdf. Accessed 27 April 2022.
    54. Tah PC, Lee ZY, Poh BK, et al. A single-center prospective observational study comparing resting energy expenditure in different phases of critical illness: indirect calorimetry versus predictive equations. Crit Care Med 2020;48:e380-90.
    55. Tah PC, Poh BK, Kee CC, et al. Do we need different predictive equations for the acute and late phases of critical illness? A prospective observational study with repeated indirect calorimetry measurements. Eur J Clin Nutr 2022;76:527-34.
    56. Duan JY, Zheng WH, Zhou H, et al. Energy delivery guided by indirect calorimetry in critically ill patients: a systematic review and meta-analysis. Crit Care 2021;25:1-10.
    57. Marik PE, Hooper MH. Normocaloric versus hypocaloric feeding on the outcomes of ICU patients: a systematic review and meta-analysis. Intensive Care Med 2016;42:316-23.
    58. Lee ZY, Yap CSL, Hasan MS, et al. The effect of higher versus lower protein delivery in critically ill patients : a systematic review and meta ‑ analysis of randomized controlled trials. Crit Care 2021;25:1-15.
    59. Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr 2019;38:48-79.
    60. Notz Q, Lee ZY, Menger J, et al. Omega-6 sparing effects of parenteral lipid emulsions—an updated systematic review and meta-analysis on clinical outcomes in critically ill patients. Crit Care 2022;26:1-11.
    61. Lew CC, Ong C, Mukhopadhyay A, et al. How to Feed the Critically Ill-A Review. Ann Acad Med Singap 2020;49:573-81.